Key facts
- Momentis Surgical’s last known valuation is $203.9M (Apr 2021).
- It has raised $133.2M across 2 recorded rounds; the latest was Early Stage VC ($5.9M) in Nov 2023.
- Notable investors include OurCrowd, Florida Opportunity Fund, Peregrine Ventures, Krillion Ventures, Ceros. — 16 tracked in total.
- Momentis Surgical has filed 3 Form Ds with the SEC since 2022, most recently Nov 2024 ($5.9M sold to 30 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Momentis Surgical
Funding rounds
2 roundsAbout Momentis Surgical
Developer of a surgical robotic technology intended to minimize post-operative pain and speed up recovery times. The company's technology comprises miniature, humanoid-shaped, articulated arms that mimic human dexterity and surpass human flexibility, enabling surgeons to achieve intuitive control and a new approach to laparoscopic procedures.
- Sector
- Healthcare
- HQ
- Or Yehuda, Israel
- Founded
- 2013
- Employees
- 58
- Website
- momentissurgical.com/
- Ownership
- Privately Held (backing)
Momentis Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Momentis Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Momentis Surgical in its N-PORT filings yet. We sweep new filings monthly.